CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Millions	3 Months Ended		6 Months Ended
CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Millions	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenues	$ 119,796	$ 96,428	$ 229,692	$ 186,662
Costs and expenses:
Cost of revenues	45,943	39,039	87,214	75,400
Research and development	18,219	13,808	35,251	27,364
Sales and marketing	8,403	7,101	16,009	13,273
General and administrative	6,461	5,209	10,752	8,748
Total costs and expenses	79,026	65,157	149,226	124,785
Income from operations	40,770	31,271	80,466	61,877
Other income (expense), net	97,983	2,662	135,699	13,845
Income before income taxes	138,753	33,933	216,165	75,722
Provision for income taxes	26,560	5,737	41,394	12,986
Net income	112,193	28,196	174,771	62,736
Preferred stock dividends	86	0	86	0
Net income available to common stockholders	$ 112,107	$ 28,196	$ 174,685	$ 62,736
Basic net income per common share (Note 12) (in dollars per share)	$ 9.23	$ 2.33	$ 14.41	$ 5.16
Diluted net income per common share (Note 12) (in dollars per share)	$ 9.11	$ 2.31	$ 14.24	$ 5.12

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Operating activities
Net income	$ 174,771	$ 62,736
Adjustments:
Depreciation of property and equipment	13,586	9,485
Stock-based compensation expense	14,708	11,514
Deferred income taxes	27,538	(1,596)
Loss (gain) on debt and equity securities, net	(135,803)	(11,411)
Other	3,161	1,041
Changes in assets and liabilities, net of effects of acquisitions:
Accounts receivable, net	(6,904)	(1,201)
Inventory	(7,739)	(628)
Income taxes, net	8,304	(2,434)
Other assets	(9,950)	(2,139)
Accounts payable	2,090	(327)
Accrued expenses and other liabilities	308	(1,779)
Deferred revenue	789	636
Net cash provided by operating activities	84,859	63,897
Investing activities
Purchases of property and equipment	(80,598)	(39,643)
Purchases of marketable securities	(76,480)	(39,870)
Maturities and sales of marketable securities	66,696	40,930
Purchases of non-marketable securities	(22,051)	(2,312)
Maturities and sales of non-marketable securities	1,667	873
Acquisitions, net of cash acquired, and purchases of intangible assets	(33,697)	(353)
Other investing activities	(1,359)	(363)
Net cash used in investing activities	(145,822)	(40,738)
Financing activities
Net payments related to stock-based award activities	(12,056)	(5,731)
Repurchases of stock	0	(28,306)
Dividend payments	(5,231)	(4,977)
Proceeds from issuance of common stock, net of costs	30,499	0
Proceeds from issuance of mandatory convertible preferred stock, net of costs	19,063	0
Proceeds from issuance of debt, net of costs	56,226	31,378
Repayments of debt	(5,253)	(18,397)
Proceeds from sale of interest in consolidated entities, net	3,758	400
Other financing activities	(686)	(400)
Net cash provided by (used in) financing activities	86,320	(26,033)
Effect of exchange rate changes on cash and cash equivalents	(154)	444
Net increase (decrease) in cash and cash equivalents	25,203	(2,430)
Cash and cash equivalents at beginning of period	30,708	23,466
Cash and cash equivalents at end of period	55,911	21,036
Supplemental disclosures of non-cash investing activities:
Property and equipment included in accrued liabilities and accounts payable	$ 29,113	$ 10,635

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 55,911	$ 30,708
Marketable securities	186,563	96,135
Total cash, cash equivalents, and marketable securities	242,474	126,843
Accounts receivable, net	69,175	62,886
Inventory	9,991	2,439
Other current assets	21,884	13,870
Total current assets	343,524	206,038
Non-marketable securities	131,461	68,687
Deferred income taxes	1,448	9,113
Property and equipment, net	321,212	246,597
Operating lease assets	17,694	15,221
Goodwill	57,828	33,380
Intangible assets, net	9,105	1,283
Other non-current assets	39,711	14,962
Total assets	921,983	595,281
Current liabilities:
Accounts payable	20,258	12,200
Accrued compensation and benefits	15,086	17,546
Accrued expenses and other current liabilities	73,014	55,557
Accrued revenue share	10,599	10,864
Deferred revenue	7,154	6,578
Total current liabilities	126,111	102,745
Long-term debt	98,165	46,547
Income taxes payable, non-current	11,306	9,531
Deferred income taxes	22,819	919
Operating lease liabilities	14,591	12,744
Other long-term liabilities	8,511	7,530
Total liabilities	281,503	180,016
Commitments and Contingencies (Note 10)
Stockholders’ equity:
Series A and Series B preferred stock and additional paid-in capital, $0.001 par value per share, 100 shares authorized; 6.25% mandatory convertible preferred stock, 0 and 19 shares issued and outstanding allocated equally between each series with a liquidation preference of $1,000 per share	18,023	0
Class A, Class B, and Class C stock and additional paid-in capital, $0.001 par value per share: 300,000 shares authorized (Class A 180,000, Class B 60,000, Class C 60,000); 12,088 (Class A 5,822, Class B 837, Class C 5,429) and 12,230 (Class A 5,868, Class B 835, Class C 5,527) shares issued and outstanding	131,371	93,126
Accumulated other comprehensive income (loss)	(2,285)	(1,916)
Retained earnings	493,371	324,055
Total stockholders’ equity	640,480	415,265
Total liabilities and stockholders’ equity	$ 921,983	$ 595,281